ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Pfizer booster highly effective against omicron: study

Receiving just 2 shots offers almost no protection against COVID-19 variant

An Israeli man receives a third shot of COVID-19 vaccine in Tel Aviv on Aug. 30. A local study found that a third dose offers protection against the omicron variant.   © Reuters

CAIRO/LONDON -- A third dose of the Pfizer-BioNTech coronavirus vaccine provides significant protection against the new, highly contagious omicron variant, a recent Israeli study finds.

Researchers from Sheba Medical Center in Israel and a laboratory under the country's Health Ministry compared the blood of 20 individuals who received a second Pfizer shot five to six months prior against another 20 who received a third shot a month prior.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more